| scholarly article | Q13442814 |
| P2093 | author name string | Yutaka Akiyama | |
| Kazuki Nabeshima | |||
| Masahiro Amano | |||
| Mitsuru Setoyama | |||
| Katsumi Ogata | |||
| Motoki Kurokawa | |||
| Takaaki Nishida | |||
| Shunichi Maeda | |||
| Fumiko Nakayama | |||
| P2860 | cites work | Immunohistochemical analysis of IQGAP1 expression in human colorectal carcinomas: its overexpression in carcinomas and association with invasion fronts | Q28215481 |
| p53 and MDM2 immunostaining in pulmonary blastomas and bronchogenic carcinomas | Q34385083 | ||
| Merkel cells and merkel cell tumors ultrastructure, immunocytochemistry and review of the literature | Q40150979 | ||
| Merkel cell carcinoma can be distinguished from metastatic small cell carcinoma using antibodies to cytokeratin 20 and thyroid transcription factor 1 | Q41845279 | ||
| Cytokeratin 20: a marker for diagnosing Merkel cell carcinoma | Q42468197 | ||
| Expression of c-Met correlates with grade of malignancy in human astrocytic tumours: an immunohistochemical study | Q48571377 | ||
| Evaluation of serum neural cell adhesion molecule as a new tumor marker in small cell lung cancer | Q70462786 | ||
| Neural cell adhesion molecule immunoreactivity in Merkel cells and Merkel cell tumours | Q72294060 | ||
| Merkel cell carcinoma | Q72842256 | ||
| NCAM expression in the pulmonary neural and diffuse neuroendocrine cell system | Q73326300 | ||
| JLP5B9: new monoclonal antibody against polysialylated neural cell adhesion molecule is of value in phenotyping lung cancer | Q73387700 | ||
| Analysis of thyroid transcription factor-1 and cytokeratin 20 separates merkel cell carcinoma from small cell carcinoma of lung | Q73574586 | ||
| Prognosticating tools in primary neuroendocrine (Merkel-cell) carcinomas of the skin: histopathological subdivision, DNA cytometry, cell proliferation analyses (Ki-67-immunoreactivity) and NCAM immunohistochemistry. A clinicopathological study in 25 | Q74445144 | ||
| Neural cell adhesion molecule expression: prognosis in 889 patients with resected non-small cell lung cancer | Q77585137 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biochemistry | Q7094 |
| dermatology | Q171171 | ||
| Merkel cell carcinoma | Q1711744 | ||
| P304 | page(s) | 219-224 | |
| P577 | publication date | 2003-05-01 | |
| P1433 | published in | Journal of Dermatological Science | Q15749351 |
| P1476 | title | CD56: a useful marker for diagnosing Merkel cell carcinoma | |
| P478 | volume | 31 |
| Q35111538 | Bioluminescence reporter gene imaging characterize human embryonic stem cell-derived teratoma formation |
| Q92126900 | CD56 Homodimerization and Participation in Anti-Tumor Immune Effector Cell Functioning: A Role for Interleukin-15 |
| Q91062659 | Danger is only skin deep: aggressive epidermal carcinomas. An overview of the diagnosis, demographics, molecular-genetics, staging, prognostic biomarkers, and therapeutic advances in Merkel cell carcinoma |
| Q36413487 | Evaluating blood levels of neuron specific enolase, chromogranin A, and circulating tumor cells as Merkel cell carcinoma biomarkers |
| Q79370590 | Expression profiles associated with aggressive behavior in Merkel cell carcinoma |
| Q34660299 | Initial testing (Stage 1) of the antibody-maytansinoid conjugate, IMGN901 (Lorvotuzumab mertansine), by the pediatric preclinical testing program |
| Q25257116 | Merkel cell carcinoma. |
| Q36879421 | Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors |
| Q89719194 | Syntaxin 1: A Novel Robust Immunophenotypic Marker of Neuroendocrine Tumors |
| Q41458291 | Systemic Therapy for Merkel Cell Carcinoma: What's on the Horizon? |
| Q34866209 | Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. |
| Q39488379 | Which are the cells of origin in merkel cell carcinoma? |
| Q79318035 | [Merkel cell carcinoma. Clinical and histological differential diagnosis, diagnostic approach and therapy] |
Search more.